Navigation Links
MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow
Date:5/21/2009

or More Information Contact: Angela Elsier Director of Marketing Managed Health Care Associates, Inc. 800-642-3020 X 2870 aelsier@mhainc.com


'/>"/>
SOURCE Managed Health Care Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser
2. Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
3. Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
4. Side discrepancy errors in radiology reports rare but often clinically significant
5. Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers
6. Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators
7. InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
8. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
9. Large clinical trial finds pirfenidone may help lung function in IPF patients
10. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
11. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2010)... pressure to normal levels below currently recommended ... risk of fatal or nonfatal cardiovascular disease events ... at especially high risk for cardiovascular disease events, ... to Control Cardiovascular Risk in Diabetes (ACCORD) clinical ... drug therapy of a fibrate and a statin ...
(Date:3/14/2010)... experience all the benefits of acupuncture, hypnosis and neuroprogramming without ... Wouldn,t you love to be able to Quit Smoking, Lose ... ... Lima, OH (PRWEB) March 14, 2010 -- AcuAids announces acupuncture ... ,·     Key features include the ability to ...
(Date:3/13/2010)... AND ATLANTA, GA MARCH 13, 2010 ... (Evaluation of Xience Prime versus Coronary Artery Bypass ... will compare drug-eluting stents to coronary artery bypass ... artery disease, was made today at "Optimizing PCI ... Cardiovascular Research Foundation. , "While the SYNTAX trial ...
(Date:3/13/2010)... on the hearts of police, firefighters , , SATURDAY, March ... to the collapsing World Trade Center towers appear to ... people in the general population, a new study finds. ... the American College of Cardiology,s annual meeting, in Atlanta. ... potential link between exposure to Ground Zero and early ...
(Date:3/13/2010)... to high blood pressure, heart attack, even death, study ... regular exercise such as jogging is good for the ... be even better, right? , Not so fast, ... that marathon runners have increased stiffness of the large ... actually be bad for the heart, potentially leading to ...
Breaking Medicine News(10 mins):Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 4Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 5Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 6Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 2Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 3Health News:EXCEL trial will determine safety and efficacy of drug-eluting stents vs. bypass surgery 2Health News:Many WTC Responders Show Signs of Heart Trouble 2Health News:Many WTC Responders Show Signs of Heart Trouble 3Health News:Marathoners Face Greater Risk of Artery Stiffness 2
... N.J., April 3 MedQuist Inc. (Nasdaq: MEDQ ... its new Senior Vice President of Sales and Marketing. ... and the positioning and promotion of MedQuist. "We are pleased ... President and CEO. "He brings an extensive knowledge and ...
... of Veterans Affairs (VA) has announced 3,174 Veterans have ... underwent recently; that testing was conducted because of improperly ... their care. These Veterans, in the Tennessee, Georgia ... letters offering free testing. VA patients, who believe that ...
... to poorer scores on cognitive tests , , FRIDAY, April 3 (HealthDay ... the life span may be taking a toll on the brains ... study shows that women aged 47 to 74 who tested positive ... metal) or bones (an indication of cumulative exposure over the life ...
... Company, Inc. will host an upcoming Illinois Venture Capital ... The event will be held at the UBS ... a.m. Wednesday, April 22. Reginald McGaugh, Managing Director, ... discussion with executives from some of the most successful ...
... -- SOKO Fitness & Spa,Group, Inc. (OTC Bulletin Board: ... Northeast China, on April 1, 2009. The latest SOKO ... has signed up more,than 500 Spa members since that ... located inside the Blessing Hot Spring Business Club,No.332, Xinyang ...
... PHILADELPHIA, April 3 Hahnemann University Hospital,s ventricular ... of Approval(TM) for health care quality. Ventricular assist ... hearts to continue functioning while patients either await ... transplant is not a viable option."Hahnemann sought accreditation ...
Other Medicine News:Health News:MedQuist Names Alan J. Gold as Senior Vice President, Sales and Marketing 2Health News:VA Continues Notification Process for Veterans Affected by Reprocessing Issues 2Health News:Accumulated Lead May Affect Older Women's Brains 2Health News:Houlihan Smith to Host Illinois Venture Capital Association Luncheon Seminar on Midwest Healthcare Investing 2Health News:SOKO Fitness & Spa Group, Inc. Opens Xinyang Spa in Harbin 2Health News:Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices 2
(Date:3/11/2010)... The U.S. Food and Drug ... new drug application (sNDA) of a new six-month ... Depot (leuprolide acetate for depot ... advanced prostate cancer.  Palliative treatment helps to relieve ... works by suppressing the production of the hormone ...
(Date:3/11/2010)... March 10-11, 2010 , the Joint Advisory Committees of the U.S. Food ... and Risk Management Advisory Committees -- discussed the design of post-marketing safety studies ... fumarate dihydrate). , ... ... , ...
(Date:3/11/2010)... N.C. , March 11 With patent expiration a ... on increased importance. It,s against this backdrop that new product planning groups ... of meeting timelines and delivering commercial insights. , ... ... ...
Breaking Medicine Technology:Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 2Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 3Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 4Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 5Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 6Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 7AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 2AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 3AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 4AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 5AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 6AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 7AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 8Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 2Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 3Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 4Carnegie Mellon will test ability of embedded sensors to detect onset of dementia infirmity 67916 1Carnegie Mellon will test ability of embedded sensors to detect onset of dementia infirmity 67916 2Carnegie Mellon will test ability of embedded sensors to detect onset of dementia infirmity 67916 3Carnegie Mellon will test ability of embedded sensors to detect onset of dementia infirmity 67916 4A rocking good lecture 12147 1A rocking good lecture 12147 2Supermarket lighting enhances nutrient level of fresh spinach 12144 1
... ANTIPOLIS, France, Oct. 2 NicOx S.A.,(Eurolist: ... clinical and,preclinical results from its collaboration with ... of Dermatology, in Buenos Aires, Argentina.,These included ... prototype compound, showing,the potential for improved safety ...
... Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) today announced that ... overview of the Company,s cancer,pipeline at the upcoming William ... City. Dr. Henderson,s presentation will take place,on Wednesday, October ... will be webcast live and will be,accessible from the ...
Other Medicine Technology:NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 2NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 3Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2
... line of flowmeters, available in oxygen, air, heliox and ... variety of calibrations to best suit your application. With ... in use, the Amvex Flowmeter is a user friendly ... I. For Power Take-Off add PT to the end ...
... available in oxygen, air, heliox and CO 2 . ... to best suit your application. With color coded labels ... Amvex Flowmeter is a user friendly device., ,For ... Take-Off add PT to the end of the part ...
0-3.5 LPM Oxygen Flowmeter 1/8" NPT Female inlet...
(1/2-8 LPM), 50 psi, 1/ 8" NPT female back inlet...
Medicine Products: